Humacyte CEO: citizen petition is baseless; signatories have conflicts of interest

Humacyte, Inc.

CEO Laura Niklason says petition signed by Robert E. Lee and Hooman Noorchashm is 'without merit'.
States Lee left FDA last fall and now heads Echelon, which advises Phraxis, a competitor.
Notes Noorchashm has filed nine prior FDA petitions with no resulting agency action.
Company will respond to the FDA at the appropriate time, calling claims 'false and harmful'.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.